U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07354672) titled 'Pathogen-Reduced Platelet Concentrates: Experience in Routine Practice in Germany' on Nov. 26, 2025.
Brief Summary: * Overall objective: to accumulate further experience with the use of pathogen-reduced platelet concentrates throughout the entire process chain from manufacture to clinical use of pathogen-reduced platelet concentrates and their efficacy and safety under real-world conditions. The study aims to better understand the impact of pathogen inactivation on the various steps of the overall supply chain in routine practice, whereby safety, measured in terms of the frequency of serious transfusion reactions and the type, imput...